Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
Publication
, Journal Article
Shen, X; Chalkias, S; Feng, J; Chen, X; Zhou, H; Marshall, J-C; Girard, B; Tomassini, JE; Aunins, A; Das, R; Montefiori, DC
Published in: N Engl J Med
September 29, 2022
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 29, 2022
Volume
387
Issue
13
Start / End Page
1234 / 1236
Location
United States
Related Subject Headings
- Vaccination
- Spike Glycoprotein, Coronavirus
- SARS-CoV-2
- Humans
- General & Internal Medicine
- COVID-19
- Antibodies, Viral
- Antibodies, Neutralizing
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shen, X., Chalkias, S., Feng, J., Chen, X., Zhou, H., Marshall, J.-C., … Montefiori, D. C. (2022). Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination. N Engl J Med, 387(13), 1234–1236. https://doi.org/10.1056/NEJMc2210648
Shen, Xiaoying, Spyros Chalkias, Jing Feng, Xing Chen, Honghong Zhou, Jean-Claude Marshall, Bethany Girard, et al. “Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.” N Engl J Med 387, no. 13 (September 29, 2022): 1234–36. https://doi.org/10.1056/NEJMc2210648.
Shen X, Chalkias S, Feng J, Chen X, Zhou H, Marshall J-C, et al. Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination. N Engl J Med. 2022 Sep 29;387(13):1234–6.
Shen, Xiaoying, et al. “Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.” N Engl J Med, vol. 387, no. 13, Sept. 2022, pp. 1234–36. Pubmed, doi:10.1056/NEJMc2210648.
Shen X, Chalkias S, Feng J, Chen X, Zhou H, Marshall J-C, Girard B, Tomassini JE, Aunins A, Das R, Montefiori DC. Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination. N Engl J Med. 2022 Sep 29;387(13):1234–1236.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
September 29, 2022
Volume
387
Issue
13
Start / End Page
1234 / 1236
Location
United States
Related Subject Headings
- Vaccination
- Spike Glycoprotein, Coronavirus
- SARS-CoV-2
- Humans
- General & Internal Medicine
- COVID-19
- Antibodies, Viral
- Antibodies, Neutralizing
- 42 Health sciences
- 32 Biomedical and clinical sciences